Naoya Mimura

3.3k total citations
84 papers, 1.8k citations indexed

About

Naoya Mimura is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Naoya Mimura has authored 84 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 31 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Naoya Mimura's work include Multiple Myeloma Research and Treatments (22 papers), Histone Deacetylase Inhibitors Research (11 papers) and Protein Degradation and Inhibitors (9 papers). Naoya Mimura is often cited by papers focused on Multiple Myeloma Research and Treatments (22 papers), Histone Deacetylase Inhibitors Research (11 papers) and Protein Degradation and Inhibitors (9 papers). Naoya Mimura collaborates with scholars based in Japan, United States and Singapore. Naoya Mimura's co-authors include Teru Hideshima, Kenneth C. Anderson, Nikhil C. Munshi, Güllü Görgün, Paul G. Richardson, Diana Cirstea, Hiroto Ohguchi, Tomohiko Aoe, Haruhiko Koseki and Yu‐Tzu Tai and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Naoya Mimura

80 papers receiving 1.8k citations

Peers

Naoya Mimura

HEMAT

ONCOL

IMMUN

Francis X. Farrell United States

David J. Elzi United States

Marianna H. Antonelou Greece

Markus Bender Germany

Mauro Torti Italy

Toshiyuki Kitano Japan

Matthias Canault France

Richard Brandl Germany

Stephen J. Klaus United States

Giovanni Maria Garbarino Italy

Francis X. Farrell United States

Naoya Mimura

779 ×0.9

589 ×1.1

HEMAT

302 ×0.8

ONCOL

127 ×0.5

277 ×1.3

IMMUN

Citations per year, relative to Naoya Mimura Naoya Mimura (= 1×) peers Francis X. Farrell

Countries citing papers authored by Naoya Mimura

Since Specialization

Citations

This map shows the geographic impact of Naoya Mimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoya Mimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoya Mimura more than expected).

Fields of papers citing papers by Naoya Mimura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoya Mimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoya Mimura. The network helps show where Naoya Mimura may publish in the future.

Co-authorship network of co-authors of Naoya Mimura

This figure shows the co-authorship network connecting the top 25 collaborators of Naoya Mimura. A scholar is included among the top collaborators of Naoya Mimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoya Mimura. Naoya Mimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsukamoto, Shokichi, Yusuke Takeda, Chikako Ohwada, et al.. (2024). Clinical impact of airflow obstruction after allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 120(4). 501–511. 1 indexed citations

Bolanos, Lyndsey, Kwangmin Choi, Shokichi Tsukamoto, et al.. (2024). Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia. 38(5). 1032–1045. 3 indexed citations

Ohwada, Chikako, Shingo Yamazaki, Katsuhiro Shono, et al.. (2021). Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation. International Journal of Hematology. 114(6). 664–673. 2 indexed citations

Tsukamoto, Shokichi, Miki Yamazaki, Yutaro Hino, et al.. (2021). Successful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Behçet-like disease. SHILAP Revista de lepidopterología. 16. 100278–100278. 2 indexed citations

Takamatsu, Hiroyuki, Naoki Takezako, Takeshi Yamashita, et al.. (2020). Minimal Residual Disease in Autografts and Bone Marrow of Patients with Multiple Myeloma: 8-Color Multiparameter Flow Cytometry (EuroFlow-NGF) Vs. Next-Generation Sequencing. Blood. 136(Supplement 1). 22–23. 2 indexed citations

Ohwada, Chikako, Yutaro Hino, Kensuke Kayamori, et al.. (2020). Successful second autologous stem-cell transplantation for patients with relapsed and refractory POEMS syndrome. Bone Marrow Transplantation. 56(2). 517–520. 6 indexed citations

Nakamura, Ayako, Chikako Ohwada, Masahiro Takeuchi, et al.. (2019). Detection of MYD88 L265P mutation by next-generation deep sequencing in peripheral blood mononuclear cells of Waldenström’s macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. PLoS ONE. 14(9). e0221941–e0221941. 12 indexed citations

Tsukamoto, Shokichi, Chikako Ohwada, Masahiro Takeuchi, et al.. (2019). Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis. Journal of Thrombosis and Thrombolysis. 48(1). 141–148. 3 indexed citations

Shimizu, Naomi, Tomoya Muto, Shokichi Tsukamoto, et al.. (2018). Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia. Annals of Hematology. 97(4). 655–662. 17 indexed citations

10.

Ohwada, Chikako, Emiko Sakaida, Tomoya Muto, et al.. (2018). Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome. Blood. 131(19). 2173–2176. 23 indexed citations

11.

Muto, Tomoya, Naoya Mimura, Shokichi Tsukamoto, et al.. (2018). Long-term complete remission following tandem autologous stem cell transplantation and consolidative radiotherapy for refractory mediastinal gray-zone lymphoma. International Journal of Hematology. 108(4). 452–455. 2 indexed citations

12.

Mimura, Naoya, Motohiko Oshima, Atsunori Saraya, et al.. (2017). Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition. Clinical Cancer Research. 23(16). 4817–4830. 60 indexed citations

13.

Ohguchi, Hiroto, Teru Hideshima, Manoj Bhasin, et al.. (2016). The KDM3A–KLF2–IRF4 axis maintains myeloma cell survival. Nature Communications. 7(1). 10258–10258. 75 indexed citations

14.

Muto, Tomoya, Masahiro Takeuchi, Atsuko Yamazaki, et al.. (2015). Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia. International Journal of Hematology. 102(1). 86–92. 5 indexed citations

15.

Suzuki, Rikio, Shohei Kikuchi, Takeshi Harada, et al.. (2015). Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells. PLoS ONE. 10(12). e0143847–e0143847. 19 indexed citations

16.

Hideshima, Teru, Francesca Cottini, Hiroto Ohguchi, et al.. (2015). Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma. Blood Cancer Journal. 5(5). e312–e312. 53 indexed citations

17.

Mimura, Naoya, Teru Hideshima, Toshiyasu Shimomura, et al.. (2014). Selective and Potent Akt Inhibition Triggers Anti-Myeloma Activities and Enhances Fatal Endoplasmic Reticulum Stress Induced by Proteasome Inhibition. Cancer Research. 74(16). 4458–4469. 66 indexed citations

18.

Cirstea, Diana, Teru Hideshima, Loredana Santo, et al.. (2013). Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs. Leukemia. 27(12). 2366–2375. 47 indexed citations

19.

Fabre, Claire, Naoya Mimura, Kathryn Bobb, et al.. (2012). Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma. Clinical Cancer Research. 18(17). 4669–4681. 66 indexed citations

20.

Jin, Hisayo, et al.. (2009). BiP, an endoplasmic reticulum chaperone, modulates the development of morphine antinociceptive tolerance. Journal of Cellular and Molecular Medicine. 14(12). 2816–2826. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact